Cargando…
Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism
Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternativ...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356047/ https://www.ncbi.nlm.nih.gov/pubmed/30740299 http://dx.doi.org/10.1016/j.rmcr.2019.01.017 |
_version_ | 1783391451477966848 |
---|---|
author | Lee, Hong Lyeol Kim, Lucia Kim, Cheol Woo Kim, Jung Soo Nam, Hae Sung Ryu, Jeong Seon |
author_facet | Lee, Hong Lyeol Kim, Lucia Kim, Cheol Woo Kim, Jung Soo Nam, Hae Sung Ryu, Jeong Seon |
author_sort | Lee, Hong Lyeol |
collection | PubMed |
description | Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism. |
format | Online Article Text |
id | pubmed-6356047 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63560472019-02-08 Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism Lee, Hong Lyeol Kim, Lucia Kim, Cheol Woo Kim, Jung Soo Nam, Hae Sung Ryu, Jeong Seon Respir Med Case Rep Case Report Leukocytoclastic vasculitis is a disorder characterized by neutrophilic inflammation that is predominantly limited to the superficial cutaneous postcapillary venules. This condition may be idiopathic or may have a defined cause. Rivaroxaban and dabigatran have been widely used as warfarin alternatives, because of their efficacy and safety. In this case report, we describe a case of leukocytoclastic vasculitis induced by both rivaroxaban- and dabigatran-, which developed during the management of pulmonary thromboembolism. Elsevier 2019-01-25 /pmc/articles/PMC6356047/ /pubmed/30740299 http://dx.doi.org/10.1016/j.rmcr.2019.01.017 Text en © 2019 The Authors. Published by Elsevier Ltd. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Lee, Hong Lyeol Kim, Lucia Kim, Cheol Woo Kim, Jung Soo Nam, Hae Sung Ryu, Jeong Seon Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title | Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title_full | Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title_fullStr | Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title_full_unstemmed | Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title_short | Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
title_sort | case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6356047/ https://www.ncbi.nlm.nih.gov/pubmed/30740299 http://dx.doi.org/10.1016/j.rmcr.2019.01.017 |
work_keys_str_mv | AT leehonglyeol caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism AT kimlucia caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism AT kimcheolwoo caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism AT kimjungsoo caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism AT namhaesung caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism AT ryujeongseon caseofbothrivaroxabananddabigatraninducedleukocytoclasticvasculitisduringmanagementofpulmonarythromboembolism |